don't you love this stock? I understand the complaints about the pummeling it took over the last few weeks, but like you I've got a longer term view and see it as just another buying opportunity. As long as no new game changing technologies make their drugs irrelevant, in 3-5 years I could see this company easily having a market cap of $2-4B (2-4 times the current stock price). Maybe even higher but I’m not going to get too greedy. I like you have a core, buying the dips, selling the pops, and it has worked out great over the last 15 years. Seems like decent odds it can continue for another 3-5. Just don’t bet the house…maybe a family room or a kitchen, but not the house.
looks to me like shorts are covering, probably should have sold calls, or held for the gap fill to $12.5-13.5, but profits are good! Seems like the bad news is out and approval is ahead. Not expecting a rocket ship, but could get a slow, grinding gap fill. Recent pattern is opposite the market, up on down days, selling on up days, a brilliant short strategy to kill investor confidence. It's already dead, so might be overkill at this point.